Bio-Matrix Scientific Group, Inc. Announces Negotiations with Four Companies for Storage of Peripheral Blood Related Stem Cells

SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) announced today that it is currently in negations with four companies to provide storage for peripheral blood related stem cell specimens. It is anticipated that, in the event that negotiations are successful, an excess of 15,000 specimens may be stored by the Company in the first year generating average revenue of $650 per specimen.

The Company is also in separate negotiations for the storage of cord blood specimens and believes it may store approximately 38,000 transfer specimens over the next 12 months in the event that negotiations for the storage of those specimens are successful.

As these contracts are finalized, they will be publicly released.

About Bio-Matrix Scientific Group, Inc.

Bio-Matrix Scientific Group Inc. (www.BMSN.us) is a biotechnology company that seeks to operate stem cell banking for the storage of adult stem cell and cord blood. Additionally, the company seeks to commercialize medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix operates a 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego's biotechnology corridor. The Company anticipates opening its facility for specimen storage in the first half of 2008. It will house Bio-Matrix's secure Cryogenic Stem Cell Bank, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.

DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.